P. Adamski

发表

A case of a patient treated with percutaneous edge-to-edge mitral valve repair, percutaneous left atrial appendage occlusion and implantable cardioverter-defibrillator

A. Sukiennik, T. Fabiszak, Wioleta Stolarek, 2019, Medical Research Journal.

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study

M. Marszałł, J. Sikora, J. Kubica, 2017, BMJ Open.

Anti-aggregation therapy in patients with acute coronary syndrome - recommendations for medical emergency teams. Experts' standpoint.

J. Wójcik, D. Dudek, W. Banasiak, 2017, Kardiologia polska.

Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite?

M. Marszałł, J. Sikora, J. Kubica, 2016, Thrombosis and Haemostasis.

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor

J. Kubica, K. Kościelska-Kasprzak, W. Kuliczkowski, 2022, Journal of clinical medicine.

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

G. Specchia, A. Budaj, D. Dudek, 2021, Cardiology journal.

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

J. Wójcik, G. Specchia, A. Budaj, 2021, Cardiology journal.

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines.

G. Specchia, A. Budaj, D. Dudek, 2020, Cardiology journal.

ISAR-REACT 5 : should this trial change clinical practice ?

J. Kubica, P. Adamski, Piotr Adamski, 2019 .

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint.

J. Wójcik, D. Dudek, W. Banasiak, 2018, Cardiology journal.

Metabolism of ticagrelor in patients with acute coronary syndromes

D. Gorog, E. Navarese, J. Sikora, 2018, Scientific Reports.

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

M. Marszałł, E. Navarese, B. Jilma, 2015, European heart journal.

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial

J. Kubica, G. Grześk, M. Koziński, 2015, Trials.

Prevalence of electrocardiographic left ventricular hypertrophy among patients with coronary artery disease and diabetes mellitus

M. Gruchała, J. Bellwon, Piotr Niezgoda, 2016 .

Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations

E. Navarese, J. Kubica, P. Adamski, 2018, Expert opinion on pharmacotherapy.

Impact of ticagrelor administration strategy on its pharmacokinetics and pharmacodynamics in patients with unstable angina pectoris: a protocol of a randomized study

M. Marszałł, J. Sikora, Piotr Niezgoda, 2016 .

The rationale for Multilevel Educational and Motivational Intervention in Patients after Myocardial Infarction (MEDMOTION) project is to support multicentre randomized clinical trial Evaluating Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndro

B. Sulikowska, Rafał Donderski, J. Kubica, 2020, Medical Research Journal.

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.

M. Marszałł, D. Alexopoulos, E. Navarese, 2019, European heart journal. Cardiovascular pharmacotherapy.

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

D. Alexopoulos, E. Navarese, B. Jilma, 2018, European heart journal. Cardiovascular pharmacotherapy.

Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors

E. Navarese, J. Kubica, G. Grześk, 2014, Thrombosis and Haemostasis.

Impact of COVID‐19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV‐HF‐SIRIO 6 study)

A. Budaj, T. Zdrojewski, P. Jankowski, 2021, ESC heart failure.

Mild therapeutic hypothermia for patients with acute coronary syndrome and cardiac arrest treated with percutaneous coronary intervention (UNICORN). The design and rationale for the prospective, observational, multicenter study

M. Gruchała, J. Kubica, M. Koziński, 2016 .

Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022

J. Kasprzak, S. Grajek, P. Jankowski, 2022, Cardiology journal.

Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest.

M. Noc, M. Marszałł, J. Kubica, 2013, Cardiology journal.

Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study

A. Budaj, T. Zdrojewski, P. Jankowski, 2022, Reviews in cardiovascular medicine.

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study

M. Marszałł, E. Navarese, B. Jilma, 2021, Cardiology journal.

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial

E. Navarese, J. Gorący, M. Lesiak, 2021, BMJ Open.

Polish trials influencing 2017 European Society of Cardiology guidelines on acute myocardial infarction in patients presenting with ST-segment elevation

P. Adamski, M. Ostrowska, Piotr Adamski, 2017, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors.

P. Gurbel, E. Navarese, B. Jilma, 2016, International journal of cardiology.

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

M. Marszałł, E. Navarese, J. Sikora, 2017, PloS one.

Does morphine administration affect ticagrelor conversion to its active metabolite in patients with acute myocardial infarction? A sub-analysis of the randomized, double-blind, placebo- -controlled IMPRESSION trial

M. Marszałł, P. Szarwas, J. Kubica, 2015 .

Unilateral generalized morphea: a case report and literature review

R. Czajkowski, P. Adamski, Kaja Męcińska-Jundziłł, 2018, Postepy dermatologii i alergologii.

Pharmacodynamic and clinical efficacy of reduced ticagrelor maintenance doses in patients with coronary artery disease

E. Navarese, J. Kubica, P. Adamski, 2020, Current medical research and opinion.

PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection

G. Specchia, M. Rupji, G. Przybylski, 2023, Journal of the American College of Cardiology.

IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study

E. Navarese, J. Kubica, J. Pinkas, 2021, Cardiology journal.